Neoadjuvant long-course chemoradiation plus Tislelizumab (anti-PD1) for MMR-status-unscreened locally advanced rectal cancer: study protocol for a phase II, 3-arm, randomized trial
Tislelizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Neoadjuvant long-course chemoradiation plus Tislelizumab (anti-PD1) for MMR-status-unscreened locally advanced rectal cancer: study protocol for a phase II, 3-arm, randomized trial ### Output: Tislelizumab